153 related articles for article (PubMed ID: 1128771)
1. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
Ciammaichella A; Solitro A; Arcuri P
Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
[No Abstract] [Full Text] [Related]
2. [Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities].
Ciammaichella A; Solitro A; Arcuri P
Clin Ter; 1975 Jul; 74(1):55-62. PubMed ID: 1222517
[No Abstract] [Full Text] [Related]
3. [Clinical trial of cinnarizine in some vascular diseases].
Triandaf I; Cosma M; Triandaf N
Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
[No Abstract] [Full Text] [Related]
4. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
Belonog RP; Karaban' IN
Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
[No Abstract] [Full Text] [Related]
5. Clinicopharmacological examination of Stugeron (Cinnarizine) in geriatric patients.
Graber H; Ternovszky E
Ther Hung; 1978; 26(3):124-6. PubMed ID: 725815
[No Abstract] [Full Text] [Related]
6. [Effect of a single dose of cinnarizine on the peripheral flow and renogram of arteriosclerotic patients].
Indovina I; Salerno L; Custro N
Minerva Cardioangiol; 1980 May; 28(5):355-8. PubMed ID: 7207825
[No Abstract] [Full Text] [Related]
7. [Experience in the treatment of leg ulcer with Stutgeron].
Mund-Hoym WD
Med Welt; 1976 Jun; 27(25):1251-4. PubMed ID: 933813
[No Abstract] [Full Text] [Related]
8. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
Sobczyk W; Kruszewska J; Szymchel J
Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
[TBL] [Abstract][Full Text] [Related]
9. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
[No Abstract] [Full Text] [Related]
10. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
Reimann-Hunziker R; Reimann-Hunziker GJ
Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
[No Abstract] [Full Text] [Related]
11. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
Caruzzo C; Enrico-Bena L; Carnaghi R
Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
[No Abstract] [Full Text] [Related]
12. [Non-invasive diagnosis and medical therapy of cerebral and/or peripheral atherosclerotic vasculopathies].
Rezzo R; Stabilini L; Bertoglio C; Ruben G; De Gregori M; Fontana G; Gori A; Petrilli GL
Clin Ter; 1984 Dec; 111(6):495-511. PubMed ID: 6396028
[No Abstract] [Full Text] [Related]
13. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
Ciammaichella A; Solitro A; Torcia L; Arcuri P
Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
[No Abstract] [Full Text] [Related]
14. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
Voina S
Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
[No Abstract] [Full Text] [Related]
15. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
[No Abstract] [Full Text] [Related]
16. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
Notarbartolo A; Di Fede G; Cupidi G; Rini GB
Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
[No Abstract] [Full Text] [Related]
17. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
Veccia F
Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
[No Abstract] [Full Text] [Related]
18. [Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy].
Shtok VN; Fedorova NV; Pavlov IuV; Traĭtel' BIa
Klin Med (Mosk); 1989 Sep; 67(9):55-8. PubMed ID: 2586043
[TBL] [Abstract][Full Text] [Related]
19. [Comparative psychological studies on patients with arteriosclerotic occlussions in the lower and upper extremities and head].
Heinemann L; Sechtig K; Heine H
Dtsch Gesundheitsw; 1969 Oct; 24(44):2085-8. PubMed ID: 5385541
[No Abstract] [Full Text] [Related]
20. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
Kalimo K; Jansen CT
Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
